These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10667763)

  • 1. Head of US watchdog faces uncertain future.
    Wadman M
    Nature; 2000 Jan; 403(6768):353. PubMed ID: 10667763
    [No Abstract]   [Full Text] [Related]  

  • 2. Higher status for 'research risks' office?
    Wadman M
    Nature; 1999 Feb; 397(6720):550. PubMed ID: 10050837
    [No Abstract]   [Full Text] [Related]  

  • 3. A word to Varmus.
    Pryor D; Hatfield M; Wyden R; Waxman HA
    Hastings Cent Rep; 1996; 26(4):46-7. PubMed ID: 11644858
    [No Abstract]   [Full Text] [Related]  

  • 4. Exempt research: procedures in the intramural research program of the National Institutes of Health.
    Wichman A; Mills D; Sandler AL
    IRB; 1996; 18(2):3-5. PubMed ID: 11654755
    [No Abstract]   [Full Text] [Related]  

  • 5. The cure that killed.
    Thompson L
    Discover; 1994 Mar; 15(3):56-62. PubMed ID: 11652306
    [No Abstract]   [Full Text] [Related]  

  • 6. Half-full or half-empty? Evaluating IRB performance.
    Mishkin B; Ariand N
    Prof Ethics Rep; 1998; 11(3):4-7. PubMed ID: 11657925
    [No Abstract]   [Full Text] [Related]  

  • 7. The regulation of human experimentation in the United States--a personal odyssey.
    Katz J
    IRB; 1987; 9(1):1-6. PubMed ID: 11649890
    [No Abstract]   [Full Text] [Related]  

  • 8. The Human Genome Project.
    McCartney JJ
    Health Prog; 1992 Dec; 73(10):20-1. PubMed ID: 10122518
    [No Abstract]   [Full Text] [Related]  

  • 9. Research compliance changes will affect rules on protection of human subjects.
    Maloney DM
    Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776
    [No Abstract]   [Full Text] [Related]  

  • 10. Policy advice for Congress.
    Prot Hum Subj; 2000; ():5-6. PubMed ID: 12564439
    [No Abstract]   [Full Text] [Related]  

  • 11. Federal report says protection of human subjects is threatened by numerous factors.
    Maloney DM
    Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
    [No Abstract]   [Full Text] [Related]  

  • 12. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
    Weijer C
    IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical issues in clinical neurological research.
    Shore D; Berg K; Mullican C
    J Calif Alliance Ment Ill; 1994; 5(1):61-2. PubMed ID: 11653329
    [No Abstract]   [Full Text] [Related]  

  • 14. Science by quota: P.C. medicine.
    Satel SL
    New Repub; 1995 Feb; 212(9):14, 16. PubMed ID: 11655245
    [No Abstract]   [Full Text] [Related]  

  • 15. Federal agency keeps review committee after public comments support continuation.
    Maloney DM
    Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603
    [No Abstract]   [Full Text] [Related]  

  • 16. Making clinical trials safer for human subjects.
    Baram M
    Am J Law Med; 2001; 27(2-3):253-82. PubMed ID: 11467112
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulating human gene therapy: legislative overreaction to human subject protection failures.
    Leavitt WJ
    Adm Law Rev; 2001; 53(1):315-41. PubMed ID: 16189905
    [No Abstract]   [Full Text] [Related]  

  • 18. Federally funding human embryonic stem cell research: an administrative analysis.
    Gross GS
    Wis L Rev; 2000; 4():855-84. PubMed ID: 12664903
    [No Abstract]   [Full Text] [Related]  

  • 19. Agencies look to improve informed consent.
    Science; 1996 Aug; 273(5275):567. PubMed ID: 11644820
    [No Abstract]   [Full Text] [Related]  

  • 20. New policy on research with children is part of trend toward including more research subjects.
    Maloney DM
    Hum Res Rep; 1998 May; 13(5):1-2. PubMed ID: 11657189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.